American Research & Management Company’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-100
| Closed | -$5K | – | 347 |
|
|
2019
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 310 |
|
|
2019
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 373 |
|
|
2018
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 334 |
|
|
2018
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 336 |
|
|
2018
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 317 |
|
|
2018
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 356 |
|
|
2017
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 358 |
|
|
2017
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 337 |
|
|
2017
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 331 |
|
|
2017
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 323 |
|
|
2016
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 346 |
|
|
2016
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 361 |
|
|
2016
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 370 |
|
|
2016
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 380 |
|
|
2015
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 384 |
|
|
2015
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 398 |
|
|
2015
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 380 |
|
|
2015
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 360 |
|
|
2014
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 380 |
|
|
2014
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 383 |
|
|
2014
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 390 |
|
|
2014
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 391 |
|
|
2013
Q4 | $1K | Buy |
+100
| New | +$544 | ﹤0.01% | 377 |
|
Other funds holding ARRY
American Research & Management Company's ARRY Position: Q3 2019 in Review
American Research & Management Company sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 100 shares — an estimated $5K sold.
American Research & Management Company first reported a position in ARRY in Q4 2013 and held it in 23 quarters. The position peaked at $5K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- American Research & Management Company reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- American Research & Management Company sold 100 Array Biopharma Inc shares in Q3 2019, an estimated $5K.
- American Research & Management Company first reported a position in Array Biopharma Inc in Q4 2013 and held it in 23 quarters.
- American Research & Management Company's Array Biopharma Inc position peaked at $5K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on American Research & Management Company's 13F filing for Q3 2019, filed 31 Oct 2019.